MAP2K5 and colonic neoplasm: Pereira et al. (2016) conducted a study to explore the influence of the MEK5/ERK5 pathway on the sensitivity of colon cancer cells to 5-fluorouracil (5-FU), a commonly used chemotherapy drug.